{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:04:27Z","timestamp":1786122267284,"version":"build-2736575974"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chiesi Farmaceutici, Parma, Italy"},{"id":[{"id":"https:\/\/ror.org\/0511bn634","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sci.","Brain Sciences"],"abstract":"<jats:p>Objectives: The critical role of nerve growth factor (NGF) in neuroprotection has been demonstrated in preclinical models of neuronal injury. Here, we investigated the neuroprotective effects of intranasal CHF6467, a recombinant mutant form of human NGF lacking algogenic activity, in transient (45 min) middle cerebral artery occlusion (tMCAo). Methods: Male Wistar rats (n = 20 per group) were treated intranasally with CHF6467 (20 \u00b5g\/kg, 40 \u00b5L) or vehicle (0.9% saline, 40 \u03bcL). The first dose was administered 15 min after the onset of MCAo and the second dose 24 h later. Neurological behavioral tests were performed 24 and 48 h after tMCAo. Infarct volume was measured 48 h after tMCAo. Additionally, a separate cohort of rats underwent permanent MCAo (pMCAo) and received two intranasal doses of CHF6467 or vehicle, with long-term neurological outcome assessed 7 days later using the De Simoni neuroscore (n = 13\u201314 per group). CHF6467 levels were measured in intact brain samples from CHF6467-treated rats (n = 5) and vehicle-treated controls (n = 4). Samples were collected 2 h after the last administration. Results: CHF6467 significantly improved neurological and sensorimotor performance compared with the vehicle-treated rats. This functional effect was associated with a reduction in infarct volume that was positively correlated with neurological deficit improvement. In the pMCAo cohort, CHF6467-treated rats were more likely to achieve a favorable neurological outcome at seven days compared with the vehicle-treated animals. Intranasal CHF6467 reached the brain but showed variable and non-uniform distribution across regions. Levels were highest in the olfactory bulbs, while the cortex and striatum had lower concentrations. In vehicle-treated rats, the drug was undetectable. Conclusions: This study demonstrates the neuroprotective effects of CHF6467 against ischemic brain injury, evidenced by both functional improvement and reduction in infarct volume. Although it reaches the brain, its distribution is heterogeneous and assessed only at one time-point. Further studies should examine its longer-term distribution and underlying mechanisms.<\/jats:p>","DOI":"10.3390\/brainsci16080839","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:14:28Z","timestamp":1786094068000},"page":"839","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CHF6467 Exerts Neuroprotective Effects in the Rat Model of Acute Ischemic Stroke"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-7773","authenticated-orcid":false,"given":"Chiara","family":"Demartini","sequence":"first","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino, 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Facchinetti","sequence":"additional","affiliation":[{"name":"Research & Development, Chiesi Farmaceutici, Largo Belloli 11\/A, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Blandini","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, 27100 Pavia, Italy"},{"name":"Ca\u2019Granda IRCCS Foundation-Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-2113","authenticated-orcid":false,"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino, 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-8622","authenticated-orcid":false,"given":"Francesca","family":"Malerba","sequence":"additional","affiliation":[{"name":"Fondazione EBRI\u2014Rita Levi-Montalcini, Viale Regina Elena, 295, 00161 Rome, Italy"},{"name":"Institute of Nanotechnology National Research Council (CNR Nanotec) c\/o Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Fondazione EBRI\u2014Rita Levi-Montalcini, Viale Regina Elena, 295, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7513-3495","authenticated-orcid":false,"given":"Diana","family":"Amantea","sequence":"additional","affiliation":[{"name":"Section of Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Savinio, I-87036 Rende, CS, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-7262","authenticated-orcid":false,"given":"Bruno P.","family":"Imbimbo","sequence":"additional","affiliation":[{"name":"Research & Development, Chiesi Farmaceutici, Largo Belloli 11\/A, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-0629","authenticated-orcid":false,"given":"Rosaria","family":"Greco","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino, 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/pr.2013.206","article-title":"Intrapartum-Related Neonatal Encephalopathy Incidence and Impairment at Regional and Global Levels for 2010 with Trends from 1990","volume":"74","author":"Lee","year":"2013","journal-title":"Pediatr. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.STR.25.9.1794","article-title":"Role of Angiogenesis in Patients with Cerebral Ischemic Stroke","volume":"25","author":"Krupinski","year":"1994","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1202","DOI":"10.1038\/cddis.2014.173","article-title":"Nerve Growth Factor-Mediated Inhibition of Apoptosis Post-Caspase Activation Is Due to Removal of Active Caspase-3 in a Lysosome-Dependent Manner","volume":"5","author":"Mnich","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","article-title":"Nerve Growth Factor: A Focus on Neuroscience and Therapy","volume":"13","author":"Aloe","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4142\/jvs.2001.2.2.125","article-title":"Angiogenesis Effects of Nerve Growth Factor (NGF) on Rat Corneas","volume":"2","author":"Seo","year":"2001","journal-title":"J. Vet. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"P\u00f6yh\u00f6nen, S., Er, S., Domanskyi, A., and Airavaara, M. (2019). Effects of Neurotrophic Factors in Glial Cells in the Central Nervous System: Expression and Properties in Neurodegeneration and Injury. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00486"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Minnone, G., De Benedetti, F., and Bracci-Laudiero, L. (2017). NGF and Its Receptors in the Regulation of Inflammatory Response. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051028"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/brain\/aww271","article-title":"The Chemokine CXCL12 Mediates the Antiamyloidogenic Action of Painless Human Nerve Growth Factor","volume":"140","author":"Capsoni","year":"2017","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Manni, L., Conti, G., Chiaretti, A., and Soligo, M. (2021). Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.754502"},{"key":"ref_10","first-page":"3481","article-title":"Intranasal Administration of Nerve Growth Factor Promotes Angiogenesis via Activation of PI3K\/Akt Signaling Following Cerebral Infarction in Rats","volume":"10","author":"Li","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/10717544.2011.557785","article-title":"Intranasal Nerve Growth Factor Enhances Striatal Neurogenesis in Adult Rats with Focal Cerebral Ischemia","volume":"18","author":"Zhu","year":"2011","journal-title":"Drug Deliv."},{"key":"ref_12","first-page":"257","article-title":"Intranasal Delivery of Nerve Growth Factor to Protect the Central Nervous System against Acute Cerebral Infarction","volume":"19","author":"Zhao","year":"2004","journal-title":"Chin. Med. Sci. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neulet.2017.01.046","article-title":"NGF Protects against Oxygen and Glucose Deprivation-Induced Oxidative Stress and Apoptosis by up-Regulation of HO-1 through MEK\/ERK Pathway","volume":"641","author":"Sun","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-6147(99)01444-3","article-title":"Development of Pharmacological Agents for Targeting Neurotrophins and Their Receptors","volume":"21","author":"Saragovi","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1398-9995.1997.tb01247.x","article-title":"The Expanding Role of Nerve Growth Factor: From Neurotrophic Activity to Immunologic Diseases","volume":"52","author":"Aloe","year":"1997","journal-title":"Allergy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000052077","article-title":"Neurotrophic Factors and Diabetic Peripheral Neuropathy","volume":"41","author":"Apfel","year":"1999","journal-title":"Eur. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve Growth Factor for the Treatment of Diabetic Neuropathy: What Went Wrong, What Went Right, and What Does the Future Hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/annotation\/97b6c799-1ebc-4e7b-8f86-47c1130dc00e","article-title":"Correction: Intranasal \u201cPainless\u201d Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice","volume":"7","author":"Capsoni","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Malerba, F., Paoletti, F., Ercole, B.B., Materazzi, S., Nassini, R., Coppi, E., Patacchini, R., Capsoni, S., Lamba, D., and Cattaneo, A. (2015). Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a \u201cPainless\u201d Lead Investigational Candidate for Therapeutic Applications. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136425"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"du Sert, N.P., Hurst, V., Ahluwalia, A., Alam, S., Avey, M.T., Baker, M., Browne, W.J., Clark, A., Cuthill, I.C., and Dirnagl, U. (2020). The Arrive Guidelines 2.0: Updated Guidelines for Reporting Animal Research. PLoS Biol., 18.","DOI":"10.1371\/journal.pbio.3000410"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/bph.17353","article-title":"Beneficial Effects of CHF6467, a Modified Human Nerve Growth Factor, in Experimental Neonatal Hypoxic\u2013Ischaemic Encephalopathy","volume":"182","author":"Landucci","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2014.10.006","article-title":"Neuroprotection by the PARP Inhibitor PJ34 Modulates Cerebral and Circulating RAGE Levels in Rats Exposed to Focal Brain Ischemia","volume":"744","author":"Greco","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat Middle Cerebral Artery Occlusion: Evaluation of the Model and Development of a Neurologic Examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rewell, S.S.J., Churilov, L., Sidon, T.K., Aleksoska, E., Cox, S.F., Macleod, M.R., and Howells, D.W. (2017). Evolution of Ischemic Damage and Behavioural Deficit over 6 Months after MCAo in the Rat: Selecting the Optimal Outcomes and Statistical Power for Multi-Centre Preclinical Trials. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171688"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.hest.2020.09.001","article-title":"Behavioral Tests in Rodent Models of Stroke","volume":"1","author":"Ruan","year":"2020","journal-title":"Brain Hemorrhages"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Amantea, D., La Russa, D., Frisina, M., Giordano, F., Di Santo, C., Panno, M.L., Pignataro, G., and Bagetta, G. (2022). Ischemic Preconditioning Modulates the Peripheral Innate Immune System to Promote Anti-Inflammatory and Protective Responses in Mice Subjected to Focal Cerebral Ischemia. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.825834"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1161\/STROKEAHA.125.051532","article-title":"Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC)","volume":"56","author":"Beretta","year":"2025","journal-title":"Stroke"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1038\/s41598-017-09705-0","article-title":"NogoA Neutralization Promotes Axonal Restoration after White Matter Injury in Subcortical Stroke","volume":"7","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4103\/1673-5374.270416","article-title":"Effects of CXCR7-Neutralizing Antibody on Neurogenesis in the Hippocampal Dentate Gyrus and Cognitive Function in the Chronic Phase of Cerebral Ischemia","volume":"15","author":"Dong","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/STROKEAHA.111.646224","article-title":"Axonal Outgrowth and Dendritic Plasticity in the Cortical Peri-Infarct Area after Experimental Stroke","volume":"43","author":"Ueno","year":"2012","journal-title":"Stroke"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.14789\/jmj.JMJ23-0025-R","article-title":"Mechanism of Post-Stroke Axonal Outgrowth and Functional Recovery","volume":"69","author":"Ueno","year":"2023","journal-title":"Juntendo Med. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1016\/j.apsb.2025.04.024","article-title":"Discovery of Powerful Multifaceted Antioxidant for Combating Oxidative Stress Associated with Neurodegenerative Disorders","volume":"15","author":"Khan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2011.01398.x","article-title":"Preclinical Stroke Research\u2014Advantages and Disadvantages of the Most Common Rodent Models of Focal Ischaemia","volume":"164","author":"Macrae","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101715","DOI":"10.1016\/j.tice.2021.101715","article-title":"Systematic Comparison of Basic Animal Models of Cerebral Hypoperfusion","volume":"75","author":"Chrishtop","year":"2022","journal-title":"Tissue Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2017.04.001","article-title":"Optimization of Behavioural Tests for the Prediction of Outcomes in Mouse Models of Focal Middle Cerebral Artery Occlusion","volume":"1665","author":"Wen","year":"2017","journal-title":"Brain Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0006-8993(00)02100-4","article-title":"Neurological Impairment in Rats after Transient Middle Cerebral Artery Occlusion: A Comparative Study under Various Treatment Paradigms","volume":"863","author":"Zausinger","year":"2000","journal-title":"Brain Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/STROKEAHA.119.026652","article-title":"Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion","volume":"50","author":"Bieber","year":"2019","journal-title":"Stroke"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/08977194.2022.2060095","article-title":"The Effects of CHF6467, a New Mutated Form of NGF, on Cell Models of Human Glioblastoma. A Comparison with Wild-Type NGF","volume":"40","author":"Lisi","year":"2022","journal-title":"Growth Factors"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/8\/839\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:29:01Z","timestamp":1786094941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/8\/839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["brainsci16080839"],"URL":"https:\/\/doi.org\/10.3390\/brainsci16080839","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}